Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Delay in Phase 1 a --------Get over it

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Mar 28, 2022 5:46pm

76 Views

Post# 34553599

RE:RE:RE:RE:RE:RE:RE:RE:RE:Delay in Phase 1 a --------Get over it

Guarantee is a strong word so it sounds like you know of what you speak. I guess there is good news and bad news in that. Good news that there is still a chance to do that analysis and bad news that it has not yet be done.

<br /> <br />

jfm1330 wrote: I can guarantee you that he is not...<br /> <br /> <br /> <blockquote class="BBQuote"> <div> <cite>SPCEO1 wrote:</cite> I am pretty sure Christian is on top of such things way more than any of us, even JFM.</div> </blockquote> <br /> <br />

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment